The purpose of the study is to determine whether the topical application of BRT-FC-83C is effective in the treatment of mild to moderate atopic dermatitis.
Atopic dermatitis is a common skin disease. BRT-FC-83C is a skin cream that does not contain corticosteroids or other anti-inflammatory components. It represents a novel class of skin barrier repair therapy for chronic dermatoses. The objective of this clinical study is to determine whether BRT-FC-83C, applied twice a day to the affected area of the skin, ameliorates signs and symptoms of mild to moderate atopic dermatitis.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
32
BRT-FC-83C is a topical cream to treat atopic dermatitis. It is applied topically, twice a day, to the atopic dermatitis skin lesion for six weeks.
Thomas J. Stephens & Associates, Inc.
Colorado Springs, Colorado, United States
Change in mean Atopic Dermatitis Severity Index (ADSI) in lesional skin at target site
Time frame: Eight weeks
Change in mean Trans Epidermal Water Loss (TEWL) in lesional skin at target site
Time frame: Eight weeks
Change in mean corneometer measurement in lesional skin at target site
Time frame: Eight weeks
Self assessment of efficacy of BRT-FC-83C on signs and symptoms of atopic dermatitis
Time frame: Eight weeks
Change in Investigator's Global Assessment (IGA) in lesional skin at target site
Time frame: Eight weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.